• Return to Headlines

Aimmune Therapeu Shares Up 7.2% Since SmarTrend's Buy Recommendation (AIMT)

By Nick Russo

SmarTrend identified an Uptrend for Aimmune Therapeu (NASDAQ:AIMT) on September 11th, 2019 at $24.73. In approximately 2 months, Aimmune Therapeu has returned 7.24% as of today's recent price of $26.52.

In the past 52 weeks, Aimmune Therapeu share prices have been bracketed by a low of $16.95 and a high of $31.83 and are now at $26.52, 56% above that low price. Over the past week, the 200-day moving average (MA) has gone up 0.4% while the 50-day MA has advanced 2.1%.

Aimmune Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on developing treatments to protect children with food allergies from accidental exposure. Aimmune Therapeutics serves customers in the United States.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Aimmune Therapeu shares.

Log in and add Aimmune Therapeu (AIMT) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights aimmune therapeu

Ticker(s): AIMT